Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CMAX

CareMax (CMAX) Stock Price, News & Analysis

CareMax logo

About CareMax Stock (NASDAQ:CMAX)

Advanced Chart

Key Stats

Today's Range
$0.40
$0.54
50-Day Range
$0.42
$2.17
52-Week Range
$0.40
$8.49
Volume
893,330 shs
Average Volume
1.42 million shs
Market Capitalization
$1.61 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida.

Receive CMAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CareMax and its competitors with MarketBeat's FREE daily newsletter.

CMAX Stock News Headlines

Trump’s tariffs just split the AI market in two
Trump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying on cheap foreign hardware—just saw their costs shoot through the roof. For the other group of AI companies, they were just handed a massive competitive advantage. Make no mistake, AI as a whole is still a game-changer for the global economy. But within the AI sector, Trump’s tariffs have created a huge divergence.
ClareMedica Health Partners To Buy CareMax's Core Centers' Assets
CareMax Seeks Restructuring Amid Chapter 11 Bankruptcy
See More Headlines

CMAX Stock Analysis - Frequently Asked Questions

CareMax, Inc. (NASDAQ:CMAX) announced its earnings results on Monday, November, 15th. The company reported ($0.90) earnings per share (EPS) for the quarter, topping the consensus estimate of ($9.90) by $9.00. The company had revenue of $104.62 million for the quarter, compared to analysts' expectations of $110.99 million. CareMax had a negative net margin of 99.78% and a negative trailing twelve-month return on equity of 175.40%.

CareMax shares reverse split on the morning of Thursday, February 1st 2024. The 1-30 reverse split was announced on Thursday, February 1st 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, February 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that CareMax investors own include Plug Power (PLUG), Workhorse Group (WKHS), FuelCell Energy (FCEL), Ovid Therapeutics (OVID), KALA BIO (KALA), Comtech Telecommunications (CMTL) and Fortress Biotech (FBIO).

Company Calendar

Last Earnings
11/15/2021
Today
4/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Nursing & personal care facilities
Sub-Industry
Healthcare
Current Symbol
NASDAQ:CMAX
Fax
N/A
Employees
1,450
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-683,350,000.00
Pretax Margin
-99.89%

Debt

Sales & Book Value

Annual Sales
$751.10 million
Price / Cash Flow
N/A
Book Value
$16.42 per share
Price / Book
0.03

Miscellaneous

Free Float
2,789,000
Market Cap
$1.61 million
Optionable
No Data
Beta
0.66
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:CMAX) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners